ADCYAP1 and diabetic kidney disease: Based on these data, PACAP is a promising therapeutic agent in both acute and chronic renal pathologies and can potentially alleviate nephrotoxicity induced by various drugs with nephrotoxic side effects and can also ameliorate damage in chronic nephropathies, like diabetic nephropathy.